Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | 0 | déclaré | 18 mars 2026 | tx 206+980 925−993 697 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22 750 | 36.75 USD | |
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 4 250 | 29.61 USD | |
| 18 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 412 | 50.48 USD | |
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 18 000 | 32.20 USD | |
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 5 000 | 27.94 USD | |
| 16 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 34 114 | 50.18 USD | |
| 16 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 15 886 | 50.49 USD | |
| 17 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22 750 | 39.40 USD | |
| 17 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 12 250 | 36.75 USD | |
| 17 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15 000 | 38.60 USD | |
| 17 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 27 710 | 49.95 USD | |
| 17 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 22 290 | 50.73 USD | |
| 18 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7 250 | 39.40 USD | |
| 18 mars 2026 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 6 838 | 49.55 USD | |
| 18 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 7 250 | 0.00 USD | deriv |
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22 750 | 0.00 USD | deriv |
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 4 250 | 0.00 USD | deriv |
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 18 000 | 0.00 USD | deriv |
| 16 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 5 000 | 0.00 USD | deriv |
| 17 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 22 750 | 0.00 USD | deriv |
| 17 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 12 250 | 0.00 USD | deriv |
| 17 mars 2026 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 25 févr. 2026 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD | |
| 25 févr. 2026 | TAX_WITHHOLDING | SUPERNUS PHARMACEUTICALS, INC. | 650 | 50.69 USD | |
| 25 févr. 2026 | OTHER | SUPERNUS PHARMACEUTICALS, INC. | 1 250 | 0.00 USD | deriv |